These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12070757)

  • 1. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
    Bigoni R; Rizzi D; Rizzi A; Camarda V; Guerrini R; Lambert DG; Hashiba E; Berger H; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):442-9. PubMed ID: 12070757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi D; Rizzi A; Zucchini M; Varani K; Hashiba E; Lambert DG; Toth G; Borea PA; Salvadori S; Regoli D
    J Med Chem; 2001 Nov; 44(23):3956-64. PubMed ID: 11689082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies.
    Rizzi A; Salis MB; Ciccocioppo R; Marzola G; Bigoni R; Guerrini R; Massi M; Madeddu P; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):450-6. PubMed ID: 12070758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
    Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A.
    Guerrini R; Calo' G; Rizzi A; Bigoni R; Rizzi D; Regoli D; Salvadori S
    Peptides; 2000 Jul; 21(7):923-33. PubMed ID: 10998526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2000 Mar; 129(6):1183-93. PubMed ID: 10725267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
    J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
    Pheng LH; Calo G; Guerrini R; Regoli D
    Eur J Pharmacol; 2000 Jun; 397(2-3):383-8. PubMed ID: 10844138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
    Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor.
    Chang M; Peng YL; Dong SL; Han RW; Li W; Yang DJ; Chen Q; Wang R
    Regul Pept; 2005 Sep; 130(3):116-22. PubMed ID: 15935490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J; Barnes TA; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Eur J Pharmacol; 2002 May; 443(1-3):7-12. PubMed ID: 12044785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.